Naya Biosciences Inc. (INVO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Naya Biosciences Inc. (INVO:NASDAQ), powered by AI.

Current Price
$1.49
P/E Ratio
-0.3
Market Cap
2M
Sector
Healthcare
What is the Naya Biosciences Inc. stock price forecast?

Naya Biosciences Inc. is currently trading at $1.49. View real-time AI analysis on Alpha Lenz.

What is Naya Biosciences Inc. insider trading activity?

View the latest insider trading data for Naya Biosciences Inc. on Alpha Lenz.

What is Naya Biosciences Inc.'s P/E ratio?

Naya Biosciences Inc.'s P/E ratio is -0.3.

Naya Biosciences Inc.

NASDAQ · INVO
$1.49+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Naya Biosciences Inc.'s future dividend policy...
Alpha Chat Insight

Naya Biosciences Inc. trades at a P/E of -0.3 (undervalued) with strong ROE of 18952.5%.

Ask for details

Company Overview

Naya Biosciences Inc. is an innovative biotechnology company specializing in advanced medical therapies and drug development. Focused on discovering and developing novel treatments for rare and life-threatening conditions, Naya Biosciences plays a critical role in improving patient outcomes across several medical fields. The company's pipeline is composed of therapies targeting genetic disorders, rare diseases, and unmet medical needs, leveraging cutting-edge technologies such as gene editing and precision medicine. With a strong commitment to research and development, Naya Biosciences often collaborates with academic institutions and pharmaceutical partners to accelerate the transition of experimental treatments from bench to bedside. Headquartered in a strategic location to facilitate collaboration and access to research talent, Naya Biosciences is crucial in reshaping the landscape of modern medicine, providing hope for patients worldwide through pioneering therapies that address significant health challenges.

CEOMr. Steven M. Shum
SectorHealthcare
IndustryMedical Devices
Employees25

Company Statistics

FY 2023

Profile

$2.33MMarket Cap
$3.02MRevenue
0.00Shares Out
25Employees

Margins

35.96%Gross
-219.38%EBITDA
-224.04%Operating
-265.08%Pre-Tax
-266.00%Net

Valuation

-0.29P/E
2.61P/B
0.77EV/Sales
-1.27EV/EBITDA
-0.45P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-71.07%ROA
18952.46%ROE
-62.64%ROIC

Financial Health

$232.42KCash & Cash Equivalents
$17.38MNet Debt
1972.74%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Naya Biosciences Inc. (ticker: INVO) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 25 employees. Market cap is $2M.

The current price is $1.49 with a P/E ratio of -0.29x and P/B of 2.61x.

ROE is 18952.46% and operating margin is -224.04%. Annual revenue is $3M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Naya Biosciences Inc. (INVO) Stock Forecast 2026 $1.49 — Price, Financials & Analyst Targets | Alpha Lenz